Company / Income Tax
Gain Therapeutics, Inc. Income Tax History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$79.3K
FY2024
5-year range
$4.0K / $93.0K
FY2021-FY2024
Trend
-14.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $4,008 to $79,275 over the past 2 years.
Based on SEC 10-K filings.
$79,275 in FY2024 with a 3-year CAGR of +145.1%.
Increased from $4,008 to $79,275 over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- +145.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +145.1%, indicating consistent growth.
- In FY2024, income tax decreased 14.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -16.87 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $79.3K | -14.7% |
| FY2023 | $93.0K | +2219.8% |
| FY2022 | $4.0K | -25.6% |
| FY2021 | $5.4K | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026